Drugs / Topical TA-102 A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03645499 | Apr 2018 → Oct 2019 | psoriasis | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Topical TA-102 A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03645499 ↗ |
| Route | Topical | “applied smoothly and evenly to affected areas” NCT03645499 ↗ |